Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Baylor1965on Sep 21, 2011 9:18am
295 Views
Post# 19065191

RE: RE: 3 messages in 7 days and No Response

RE: RE: 3 messages in 7 days and No ResponseThis is how I communicated with management in the past 5 years: I emailed them with specific questions and included my phone number. They sometime answered by email and mostly called me back within a day or so. Sometimes they couldn't divuldge the info but at least they would say "hey thanks still believing in us"....I guess angelika is gone and so far her emails and the 2 that were sent to the Alan didn't even get noticed.  They must either be really busy closing in on something or planning an exit strategy and as such distancing themselves from the current common shareholders.

Baylor.

Bullboard Posts